Trugen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 7.52 M
as on 22-06-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 Cr
as on 22-06-2024
- Satisfied Charges ₹ 1.94 Cr
as on 22-06-2024
- Revenue 3.77%
(FY 2022)
- Profit -119.33%
(FY 2022)
- Ebitda -44.37%
(FY 2022)
- Net Worth 4.22%
(FY 2022)
- Total Assets 3.88%
(FY 2022)
About Trugen Pharmaceuticals
The Corporate was formerly known as Bss Buildcon Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.52 M.
The company currently has active open charges totaling ₹6.30 Cr. The company has closed loans amounting to ₹1.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Monika Garg, Anuj Kumar, and Vivek Garg serve as directors at the Company.
- CIN/LLPIN
U24232DL2005PTC138478
- Company No.
138478
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Trugen Pharmaceuticals Private Limited offer?
Trugen Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Brain & Nervous System Drugs, Antiepileptic Drugs, Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Malaria Medicine, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Trugen Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Garg  | Managing Director | 08-Jul-2005 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monika Garg | Director | 03-Jan-2018 | Current |
| Anuj Kumar | Director | 08-Jul-2005 | Current |
Financial Performance of Trugen Pharmaceuticals.
Trugen Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.77% increase. The company also saw a substantial fall in profitability, with a 119.33% decrease in profit. The company's net worth moved up by a moderate rise of 4.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trugen Pharmaceuticals?
In 2022, Trugen Pharmaceuticals had a public holding of 27.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trugen Neurosciences Private LimitedActive 14 years 7 monthsMonika Garg and Vivek Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 13 Mar 2023 | ₹1.00 Cr | Open |
Indian Overseas Bank Creation Date: 25 Feb 2022 | ₹4.60 M | Open |
Indian Overseas Bank Creation Date: 25 Nov 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Trugen Pharmaceuticals?
Trugen Pharmaceuticals has a workforce of 26 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trugen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trugen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
